Clinical Trial Update: Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of BIA 9-1067 in healthy Japanese and Caucasian subjects; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-06-20